BIOMAT Database Logo BIOMAT Database Logo

The relevance of 25-hydroxycalciferol measurements in sera of patients with renal failure. 1979

R S Mason, and D Moddel, and A McElduff, and J H Stewart, and J F Mahony, and S Posen

Iliac crest biopsies and serum specimens were obtained from 36 non-dialyzed uraemic patients. The mean serum 25-hydroxycalciferol concentration of the patients was lower than that of normal subjects and a significant correlation was found between 25-hydroxycalciferol values and the severity of osteomalacia. Parathyroid osteopathy was significantly correlated with serum immunoreactive parathyroid hormone but not with serum 25-hydroxycalciferol values. While normal serum 25-hydroxycalciferol concentrations in uraemic patients do not exclude the presence of osteomalacia, a low concentration is virtually diagnostic of this disorder.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D010018 Osteomalacia Disorder caused by an interruption of the mineralization of organic bone matrix leading to bone softening, bone pain, and weakness. It is the adult form of rickets resulting from disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis. Adult Rickets,Rickets, Adult
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D004872 Ergocalciferols Derivatives of ERGOSTEROL formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. They differ from CHOLECALCIFEROL in having a double bond between C22 and C23 and a methyl group at C24. Calciferols,Vitamin D 2,Ergocalciferol,Vitamin D2,D2, Vitamin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen

Related Publications

R S Mason, and D Moddel, and A McElduff, and J H Stewart, and J F Mahony, and S Posen
The relevance of 25-hydroxycalciferol measurements in the treatment of hypoparathyroidism.
March 1979, Clinical endocrinology,
R S Mason, and D Moddel, and A McElduff, and J H Stewart, and J F Mahony, and S Posen
Serum 25-hydroxycalciferol concentrations in normal subjects and in haemodialysed patients with chronic renal failure.
January 1980, International urology and nephrology,
R S Mason, and D Moddel, and A McElduff, and J H Stewart, and J F Mahony, and S Posen
[Parathormone, calcitonin, 25-hydroxycalciferol and bone histology in patients with chronic renal insufficiency].
November 1979, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
R S Mason, and D Moddel, and A McElduff, and J H Stewart, and J F Mahony, and S Posen
Serum 25-hydroxycalciferol in myocardial infarction.
January 1977, Atherosclerosis,
R S Mason, and D Moddel, and A McElduff, and J H Stewart, and J F Mahony, and S Posen
[Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].
July 1976, Klinische Wochenschrift,
R S Mason, and D Moddel, and A McElduff, and J H Stewart, and J F Mahony, and S Posen
Some problems associated with assay of 25-hydroxycalciferol in human serum.
May 1977, Clinical chemistry,
R S Mason, and D Moddel, and A McElduff, and J H Stewart, and J F Mahony, and S Posen
Correlation of seasonal variation of 25-hydroxycalciferol with UV radiation dose.
September 1980, The British journal of dermatology,
R S Mason, and D Moddel, and A McElduff, and J H Stewart, and J F Mahony, and S Posen
Decreased Serum 25-Hydroxycalciferol Levels in Pre-diabetic Adults.
February 2016, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
R S Mason, and D Moddel, and A McElduff, and J H Stewart, and J F Mahony, and S Posen
Clinical effects of 25-hydroxycholecalciferol in patients with chronic renal failure.
January 1977, Journal of nutritional science and vitaminology,
R S Mason, and D Moddel, and A McElduff, and J H Stewart, and J F Mahony, and S Posen
[Determination of plasma 25-hydroxycalciferol using the competitive protein-binding method].
December 1976, Bollettino della Societa italiana di biologia sperimentale,
Copied contents to your clipboard!